  0 Table of Contents |
  1 Home |
| 2 Downloads |
| 3 Requests |
| 4 Valuesets |
 5 Artifacts Summary |
 5.1 Oncologic Adverse Event |
| 5.2 Oncology Surgery |
| 5.3 Oncology-related Medication Statement |
| 5.4 Response Evaluation |
| 5.5 Treatment |
| 5.6 Analysis |
| 5.7 Biological Sample |
| 5.8 Biomarker |
| 5.9 Cause Of Death |
| 5.10 Family Cancer History |
| 5.11 Oncology Patient |
| 5.12 Oncology Patient Related Pathology |
| 5.13 Performance Status |
| 5.14 Sequencing Analysis |
| 5.15 TNM |
| 5.16 Tumor Pathology Event |
| 5.17 Vital Status |
| 5.18 3 Prime Molecular Sequence |
| 5.19 5 Prime Molecular Sequence |
| 5.20 Annotation Reference |
| 5.21 Gene Expression |
| 5.22 Gene Fusion |
| 5.23 Genome Entity |
| 5.24 Sequencing Device |
| 5.25 Single Nucleotide Polymorphism |
| 5.26 Validation |
| 5.27 Variant Annotation |
| 5.28 Variant Copy Number |
| 5.29 Cancer Organization |
| 5.30 Clinical Trial Subject |
| 5.31 Consent for Genetic Data Usage |
| 5.32 Oncology Clinical Trial |
| 5.33 Imaging Device |
| 5.34 Imaging Service |
| 5.35 Imaging Study |
| 5.36 Imaging Study Injection |
| 5.37 Imaging Study Injection Contrast |
| 5.38 Location to the PACS server |
| 5.39 Radiomics Criteria |
| 5.40 Radiomics Features |
| 5.41 Radiomics Image Filters |
| 5.42 Radiotherapy course Summary |
| 5.43 Radiotherapy Phase |
| 5.44 Radiotherapy Plan |
| 5.45 Radiotherapy Volume Profile |
| 5.46 ROI segmentation |
| 5.47 Adverse Event End date |
| 5.48 Algorith mName |
| 5.49 Based On Condition (Tumor Pathology Event) |
| 5.50 Biological Sample Origin |
| 5.51 Connection with the imaging module |
| 5.52 Dose To Volume |
| 5.53 Energy Or Isotope |
| 5.54 Fusion Spanning Pairs |
| 5.55 Fusion Split Reads |
| 5.56 Gene Expression Data Type |
| 5.57 GenomeEntityType |
| 5.58 Histology |
| 5.59 Imaging Settings |
| 5.60 Laterality |
| 5.61 Modality And Technique |
| 5.62 Number of Fractions |
| 5.63 Number of Sessions |
| 5.64 Patient Ethnicity |
| 5.65 Patient Origin Center |
| 5.66 Radiomics Criteria Settings |
| 5.67 Radiomics Image Filters Settings |
| 5.68 Reason Replanification |
| 5.69 Strand bias |
| 5.70 Treatment Intent |
| 5.71 Treatment Line Number |
| 5.72 Treatment Termination Reason |
| 5.73 Tumor Pathology Event Parent |
| 5.74 Weight and Height at the time of the Serie |
| 5.75 Bodysite Value Set |
| 5.76 Modality Value Set |
| 5.77 Adverse Event Code Value Set |
| 5.78 Adverse Event Grade Value Set |
| 5.79 Algorithmic Ploidy |
| 5.80 Alteration Type Value Set |
| 5.81 Amino Acide Change Type Value Set |
| 5.82 Analysis Technical Protocol |
| 5.83 Analysis Types Value Set |
| 5.84 Biological Sample Nature Value Set |
| 5.85 Biological Sample Origin Value Set |
| 5.86 Biomarker Value Set |
| 5.87 Cause of death Value Set |
| 5.88 Chromosome Value Set |
| 5.89 CytoBand Value Set |
| 5.90 DNA Change Type Value Set |
| 5.91 Fusion Type Value Set |
| 5.92 Gene Expression Data Type Value Set |
| 5.93 GeneticMaterial |
| 5.94 Genome entity type Value Set |
| 5.95 GenomeBuild Value Set |
| 5.96 Localization Method Value Set |
| 5.97 Morphology Value Set |
| 5.98 Mutation prediction Value Set |
| 5.99 Osiris Validation Type |
| 5.100 Panel Name |
| 5.101 Parentage Value Set |
| 5.102 Pathogenicity Value Set |
| 5.103 Platform Name |
| 5.104 Radiomic Features Value Set |
| 5.105 Radiotherapy Category |
| 5.106 Radiotherapy Intent |
| 5.107 Radiotherapy Reason Replanification |
| 5.108 Radiotherapy Termination Reason |
| 5.109 Radiotherapy Treatment Location Qualifier Value Set |
| 5.110 Radiotherapy Volume Type Value Set |
| 5.111 Reference Type Value Set |
| 5.112 Response Status Value Set |
| 5.113 ROI Type Value Set |
| 5.114 Storage temperature Value Set |
| 5.115 Surgery Resection Quality Value Set |
| 5.116 TNM Version Value Set |
| 5.117 Topography Value Set |
| 5.118 Treatment Type Value Set |
| 5.119 Tumor Laterality Value Set |
| 5.120 Tumor Pathology Event Type Value Set |
| 5.121 Vital Status Value Set |
| 5.122 IBSI Code System |
| 5.123 Imaging Code System |
| 5.124 Osiris code system |
| 5.125 Radiotherapy Code System |
| 5.126 Requested SNOMED Codes Code System |
| 5.127 Requested SNOMED Codes Code System |
| 5.128 Series Modality Code System |
| 5.129 SNOMED Codes Code System |
| 5.130 fhir-osiris-annotation-1 |
| 5.131 fhir-osiris-annotation-reference-1 |
| 5.132 fhir-osiris-example-adverseevent-1 |
| 5.133 fhir-osiris-example-analysis-clinical |
| 5.134 fhir-osiris-example-analysis-ct |
| 5.135 fhir-osiris-example-analysis-dx |
| 5.136 fhir-osiris-example-analysis-mr |
| 5.137 fhir-osiris-example-analysis-mr-2 |
| 5.138 fhir-osiris-example-analysis-pt-nm |
| 5.139 fhir-osiris-example-biologicalsample-1 |
| 5.140 fhir-osiris-example-biologicalsample-2 |
| 5.141 fhir-osiris-example-biomarker |
| 5.142 fhir-osiris-example-causeofdeath |
| 5.143 fhir-osiris-example-consent-1 |
| 5.144 fhir-osiris-example-consent-2 |
| 5.145 fhir-osiris-example-imagingdevice-ct |
| 5.146 fhir-osiris-example-imagingdevice-dx |
| 5.147 fhir-osiris-example-imagingdevice-mr |
| 5.148 fhir-osiris-example-imagingdevice-mr-2 |
| 5.149 fhir-osiris-example-imagingdevice-pt-nm |
| 5.150 fhir-osiris-example-imagingendpoint-ct |
| 5.151 fhir-osiris-example-imagingendpoint-dx |
| 5.152 fhir-osiris-example-imagingendpoint-mr |
| 5.153 fhir-osiris-example-imagingendpoint-mr-2 |
| 5.154 fhir-osiris-example-imagingendpoint-pt-nm |
| 5.155 fhir-osiris-example-imagingstudy-ct |
| 5.156 fhir-osiris-example-imagingstudy-dx |
| 5.157 fhir-osiris-example-imagingstudy-mri |
| 5.158 fhir-osiris-example-imagingstudy-mri-2 |
| 5.159 fhir-osiris-example-imagingstudy-pt-nm |
| 5.160 fhir-osiris-example-injection-medication-pt-nm |
| 5.161 fhir-osiris-example-injection-pt-nm |
| 5.162 fhir-osiris-example-oncomedicalstatement-1 |
| 5.163 fhir-osiris-example-patient |
| 5.164 fhir-osiris-example-patient-ct-scan |
| 5.165 fhir-osiris-example-patient-dx |
| 5.166 fhir-osiris-example-patient-mr |
| 5.167 fhir-osiris-example-patient-mr-2 |
| 5.168 fhir-osiris-example-patient-pt-nm |
| 5.169 fhir-osiris-example-patient-radiotherapy |
| 5.170 fhir-osiris-example-RadiomicsCriteria |
| 5.171 fhir-osiris-example-RadiomicsFeature |
| 5.172 fhir-osiris-example-RadiomicsImageFilter |
| 5.173 fhir-osiris-example-RadiotherapyCourse-1 |
| 5.174 fhir-osiris-example-RadiotherapyCourse-2 |
| 5.175 fhir-osiris-example-RadiotherapyPhase-1 |
| 5.176 fhir-osiris-example-RadiotherapyPhase-2 |
| 5.177 fhir-osiris-example-RadiotherapyPhase-3 |
| 5.178 fhir-osiris-example-RadiotherapyPhase-4 |
| 5.179 fhir-osiris-example-RadiotherapyPhase-5 |
| 5.180 fhir-osiris-example-RadiotherapyPhase-6 |
| 5.181 fhir-osiris-example-RadiotherapyPlan-1 |
| 5.182 fhir-osiris-example-RadiotherapyVolume-1 |
| 5.183 fhir-osiris-example-RadiotherapyVolume-2 |
| 5.184 fhir-osiris-example-RadiotherapyVolume-3 |
| 5.185 fhir-osiris-example-RadiotherapyVolume-4 |
| 5.186 fhir-osiris-example-ROISegmentation |
| 5.187 fhir-osiris-example-sequencinganalysis-1 |
| 5.188 fhir-osiris-example-sequencinganalysis-2 |
| 5.189 fhir-osiris-example-sequencinganalysis-3 |
| 5.190 fhir-osiris-example-sequencingdevice-1 |
| 5.191 fhir-osiris-example-sequencingdevice-2 |
| 5.192 fhir-osiris-example-sequencingdevice-3 |
| 5.193 fhir-osiris-example-snp-1 |
| 5.194 fhir-osiris-example-surgery-1 |
| 5.195 fhir-osiris-example-surgery-2 |
| 5.196 fhir-osiris-example-treatment-1 |
| 5.197 fhir-osiris-example-treatment-2 |
| 5.198 fhir-osiris-example-treatment-radiotherapy |
| 5.199 fhir-osiris-example-TumorPathologyEvent-instance-1 |
| 5.200 fhir-osiris-example-TumorPathologyEvent-instance-2 |
| 5.201 fhir-osiris-example-validation-1 |
| 5.202 fhir-osiris-example-vitalstatus |
| 5.203 fhir-osiris-genome-entity-1 |
| 5.204 fhir-osiris-origin-organization |
| 5.205 fhir-osiris-provider-organization |
| 5.206 FhirOSIRISResponseEvaluation-1 |
| 5.207 patient-synthetic |
 5.208 Unknown |
